Paid Clinical Trials in Surprise, AZ
As of July 2026, 18 paid clinical trials are recruiting in Surprise, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Surprise offers studies at sites including Arizona Center for Cancer Care-Surprise for conditions such as Chronic Kidney Disease and Hypertension, Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by drug in Surprise
Filter results
Newly added in Surprise
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
18 clinical trials
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
CCM OPEN HF Registry
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Renal Pelvic Denervation Pilot Trial
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Top Research Study Locations in Surprise
Researchers run research studies in Surprise, AZ at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Arizona Center for Cancer Care-Surprise | Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | 3 |
| Southwest Kidney Institute | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Focal Segmental Glomerulosclerosis, Kidney Disease, Chronic | 3 |
| Emvera Health at Peak Heart & Vascular Surprise | Peripheral Arterial Disease | 1 |
| Epic Medical Research - Surprise | Chronic Obstructive Pulmonary Disease | 1 |
| Innovative Surgery Center | Lumbar Spinal Stenosis | 1 |
| Panoramic Health - Southwest Kidney Institute, PLC | Kidney Disease | 1 |
| Panoramic Health / Southwest Kidney Institute, PLC | Uncontrolled Hypertension | 1 |
| Peak Heart and Vascular | Heart Failure | 1 |
| Southwest Kidney Institute - Surprise | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Southwest Kidney Institute, PLC (SKI) - Surprise | Primary Membranous Nephropathy | 1 |
Active & Upcoming Studies in Surprise (2026)
Recruiting trials in Surprise grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (4 active studies)
Cancer & tumors (3 active studies)
Diabetes & metabolic (1 active study)
Common conditions studied in Surprise
- Chronic Kidney Disease and Hypertension (2 active studies)
- Head and Neck Squamous Cell Carcinoma (2 active studies)
- Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2 active studies)
- Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2 active studies)
- Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2 active studies)
- APOL1-Mediated Kidney Disease (1 active study)
Leading research sponsors in Surprise
- AstraZeneca
- Boehringer Ingelheim
- Eli Lilly and Company
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Surprise?
There are approximately 18 recruiting clinical trials in Surprise, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Surprise pay participants?
Most recruiting trials in Surprise compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Surprise?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Surprise?
The most common conditions under active study in Surprise include Chronic Kidney Disease and Hypertension (2), Head and Neck Squamous Cell Carcinoma (2), Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2), Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Surprise?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Surprise on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Surprise?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Surprise?
Recruiting research sites in Surprise include Arizona Center for Cancer Care-Surprise, Southwest Kidney Institute, Emvera Health at Peak Heart & Vascular Surprise, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Surprise right now?
The largest active categories in Surprise are Cardiovascular (4), Cancer & tumors (3), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.